Commercial partnerships in chronic disease management: Proceeding with caution

British Medical Journal

Volumn 320, Issue 7234, 2000, Pages 566-568

  Greenhalgh, Trisha ^a   Herxheimer, Andrew ^b   Isaacs, Anthony J ^b   Beaman, Mike ^b   Morris, Jenny ^b   Farrow, Stephen ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Barnet Health Authority   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; COMMERCIAL PHENOMENA; DISEASE MANAGEMENT; DRUG INDUSTRY; HEALTH CARE ORGANIZATION; MANAGED CARE; NATIONAL HEALTH SERVICE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SHORT SURVEY; UNITED KINGDOM;

EID: 0034716583     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.320.7234.566     Document Type: Short Survey

References (5)

1. 1 Royal Institution of Chartered Surveyors. The private finance initiative: the essential guide, London: Royal Institution of Chartered Surveyors, 1995; 1-30.
2. 2 Fairfield G, hunter DJ, Mechanic D, Roslefl F. Managed care: implications of managed care for health systems, clinicians, and patients. BMJ 1997:314:1895-8.
3. 3 Pringle M. Beware of Greeks bearing gifts. BMJ 1987;295:738-9.
4. 4 NHS executive. Commercial approaches to the NHS regarding disease management packages. Leeds: Department of Health, 1994. (EL 94/94.)
5. 5 Anon. Secondary prevention of ischarmic cardiac events. In: Clinical evidence, issue 2. London: BMJ Publications, Dec 1999;73-98.